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ABSTRACT 
Coagulation Modeling Of an Artery: A Coupled Chemical-Mechanical Approach 
Dominic I. Jarecki 
Department of Mechanical Engineering 
Texas A&M University 
 
Research Advisor: Dr. Arun Srinivasa 
Department of Mechanical Engineering 
Texas A&M University 
 
Literature Review 
 Heart disease is a leading cause of death in developed countries. It typically is a slow 
killer, with atherosclerosis slowly worsening throughout the course of a patient’s lifetime, often 
only revealing itself with traumatic circulatory failure such as heart attack or stroke. To combat 
heart disease in the long term, then, requires not just knowledge of a traumatic event itself, but 
also the slow progression that leads up to it. To this end, extensive research of the circulatory 
system has been performed to study blood flow fields formed and their interplay with 
coagulation phenomena.  
The flow behavior of blood is influenced by many factors. Most notably, the mechanical 
behavior of the blood flow and the blood vessel walls, the chemical composition of the blood, 
and the presence of geometric irregularities—whether due to genetic defects, injuries, or the 
addition of man-made objects (for instance stents or LVADs) to treat a particular health issue—
make complete analysis difficult. The associated computational cost makes full-scale 
preventative simulation (perhaps carried out over a lifetime) prohibitive. 
Focusing on mechanics based simulations, work with varying degrees of fidelity has been 
performed, usually with the data of interest including the local blood pressure, wall shear stress, 
and flow patterns ([1], [2]), and usually limited to studies of arteries.  
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Early simulations often assumed the arterial wall to be rigid, the blood to be a Newtonian 
fluid, or both (see [3], [4]), a choice necessitated by the computational challenges of coupled 
fluid-structure interaction (FSI) and variable viscosity behavior.  
Simulations with varying levels of sophistication including details such as patient specific 
data, three-dimensional models, and fluid-structure interaction (FSI) between the blood and 
arterial walls ([5], [6], [7]) have been performed, albeit usually limited to a particular blood 
vessels (such as the carotid or iliac artery bifurcations) exclusively.  
Analyses in these works have been predominantly focused on the mechanical behavior of 
an system whose response does not evolve; that is, stress-strain phenomena in the walls and 
velocity and stress of the blood flow are investigated in some system with a given (constant) 
degree of stenosis. In reality, the vascular system is the stage for constant chemical activity, 
which can alter not only the geometry (for instance increasing clotting in an area and restricting 
flow) but also mechanical properties such as the local viscosity of the blood and the rigidity of 
the arterial walls themselves. 
Research into the chemical behavior of the coagulation cascade has largely proceeded 
separately from the analysis of the mechanical phenomena observed; this is in part due to the 
complexity of the models that govern this behavior ([8], [9]). 
This difficulty is shown particularly in regards to modeling of platelet action. 
Coagulation in the vascular system is effected by synergistic mechanical action of platelets and 
chemical reaction of the clotting factors that make up the coagulation cascade. Due to the 
immense number of platelets present in blood (roughly 200 000 platelets/ L of blood for a 
healthy human adult) they present significant tracking difficulty, and most modeling efforts are 
limited to blood vessels on the order of capillaries or arterioles to keep the number of platelets 
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manageable (see [10]–[12]). However, most of the important clotting pathologies manifest 
themselves in larger blood vessels, such as the carotid. 
Predictive and diagnostic modeling patient-specific simulation requires that an 
appropriate balance be struck between accuracy and accessibility and between scope and detail. 
Previous work by the authors of this study investigated the consequences of neglecting a non-
Newtonian viscosity model, observing how Newtonian and non-Newtonian assumptions affected 
the stagnation zone size predicted downstream of a mildly stenosed area in an axisymmetric 
model of an artery.  
The goal of this work is to move towards accounting for the chemorheology of flowing 
blood, with enough simplification to enable rapid evaluation of the response. This paper assesses 
the feasibility of a reduced-order model of the coagulation cascade coupled with a stochastic 
model of platelet motion and species convection, laying groundwork for more detailed 
simulation and clinical implementation designed to remain computationally tractable for use in 
large arteries. 
Thesis Statement 
 This research work mathematically characterizes a model of coagulation dynamics, 
coupling a mechanical flow simulation with a reduced-order model of the coagulation cascade 
and a stochastic advection/diffusion equation to handle platelet motion and species convection. 
The coupled model is demonstrated in a two-dimensional reduction of an artery. 
Theoretical Framework 
 This work relies on the basic principles of fluid mechanics of a continuum; in addition to 
these, variable viscosity and other unique properties of blood must be addressed through 
additional equations.  
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Project Description 
This project introduces a simplified framework for modeling coagulation behavior in the 
vascular system, and demonstrates the response obtained in quiescent flow. Full implementation 
requires simulation of blood flow models, stochastic convection of active species, use of a set of 
reduced-order coagulation chemistry equation, and combination of the three models, potentially 
in a multi-scale set up. 
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INTRODUCTION 
 
The formation (or lack thereof) of clots in the vascular system lies at the center of the 
vast majority of cardiovascular pathology; for this reason, significant effort in understanding 
their formation and regulation is warranted. Computational study offers unique opportunity to 
perform detailed, non-invasive research of these phenomena.  
Clots are produced in the vascular system due to the synergistic mechanical action of 
platelets and chemical reaction and activation of enzymes in the coagulation cascade. 
 In the extrinsic pathway (which is injury activated and the most physiologically relevant) 
a wound in the vascular wall exposes tissue factor (TF) and collagen. Tissue factor bonds to free-
floating factor VIIa (the formation from VII encouraged by the presence of the injury) producing 
the active enzyme TF-VIIa. This in turn cleaves the peptide bond of X, forming Xa, and finally, 
Xa, when associated with factor Va as prothrombinase, catalyzes the production of thrombin 
(IIa) from prothrombin (II). 
 Thrombin holds a central role in the process, converting fibrinogen (I) into the insoluble 
fibrin (Ia), which precipitates out of the blood and forms a mesh over the injury site. Action by 
factor XIII causes the mesh to crosslink, strengthening it. When the clot is no longer needed, the 
fibrin mesh is dissolved under the action of plasmin. 
 This chemical behavior describes only half of the picture, however. Most clots formed in 
vivo consist of less than 1% fibrin by volume (see [13]); the vast majority of a clot’s volume is 
contributed by cellular material (predominantly platelets). 
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 Platelets, small discoid blood cells, float through the blood stream largely inert until 
activated by the presence of certain chemicals (including ADP, collagen, and thrombin), high 
shear, or long periods in regions of stagnant flow. 
 Once activated, platelets undergo morphological change (extending pseudopods 
outward), release chemicals to encourage activation of other platelets, and begin to aggregate 
together. 
 This growing platelet aggregate, attracted to the injury in the wall by the localized release 
of clot-encouraging chemical species (including ADP, exposed collagen, and thrombin), adheres 
and constitutes the bulk of the clot. The fibrin mesh plays a critical role in maintaining clot form 
and retaining platelets under the shear of blood flow through the vessel. 
 It is evident from the foregoing discussion that both chemical and platelet behavior play a 
critical role in the formation of a clot and neither is sufficient without the other. Simulating both 
phenomena presents unique challenges, however; in particular, the sheer number of reacting 
species and platelets, make straightforward implementation of a computational model 
impractical for clinical use. In this work, multiple simplifications of the coagulation process are 
analyzed with the intent of reducing the necessary computational load required to obtain 
clinically useful results. 
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CHAPTER I 
ALGORITHM OVERVIEW 
 
 In this study, the processes of coagulation described in the introduction are simplified and 
resolved numerically in multiple scales. 
To perform the modeling of clot formation and viscosity change in the 2D representation 
of an artery segment used in this study, the following two algorithms are proposed; one used for 
the quiescent (no advection) model demonstrated in this work, and the other for the expansion to 
general flow scenarios. (Both models expand naturally to three dimensions, but are described in 
two for simplicity of presentation.) 
The relevant section of this paper is highlighted for each algorithm; this outline should be 
kept in mind as the various pieces of the model are studied. 
Quiescent Coagulation Study 
1. (Chemical Convection) The chemical species are allowed to freely diffuse for a single time step 
(Chapter IV). 
a. Reaction begins in cells immediately adjacent the injury zone 
b. If thrombin concentration in any cell is greater than zero,    is set to a reacting value in 
that cell, adding that cell to the reaction zone 
2. (Chemical Reaction) Chemical reaction products are computed using current species 
concentrations at every spatial point in the reaction zone (a subset of the entire geometry 
determined by a minimum concentration of thrombin in the area). (Chapter III) 
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Integrated Flow Field Model 
3. (Flow Field) Using CFD code and the macroscopic geometry, the flow field is determined, using 
local viscosities existing at the beginning of the time-step, iterating until convergence is reached 
for this single time step (see Chapter II). 
4. (Chemical Convection) Using the determined u- and v-velocities of the flow field, the chemical 
species are convected for a single time step (Chapter IV). 
a. Reaction begins in cells immediately adjacent the injury zone 
b. If thrombin concentration in any cell is greater than zero,    is set to a reacting value in 
that cell, adding that cell to the reaction zone 
5. (Chemical Reaction) Chemical reaction products are computed using current species 
concentrations at every spatial point in the reaction zone (a subset of the entire geometry 
determined by a minimum concentration of thrombin in the area). (Chapter III) 
6. (Platelet Transport and Activation) Platelet motion is determined using the probabilistic model 
outlined in this paper (Chapter IV). 
a. If thrombin concentration reaches a threshold value in a cell, platelets in that cell are 
considered activated and not allowed to leave 
b. If platelet number in a cell reaches a threshold value, no additional platelets are allowed 
to enter 
7.  (Flow Simulation Update) If any quantities such as local viscosity, chemical concentrations, 
and platelet aggregate formation are changed by the reacting processes, then they are updated in 
the macroscopic geometry and the simulation recalculates the flow field. Otherwise, the same 
flow field is recycled. 
Platelet and chemical behavior is considered statistically. Many details of the physiological 
mechanisms are simplified or ignored in this study, with the goal of demonstrating a much less 
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computationally demanding framework—which can easily be scaled up to include additional 
species and greater complexity if necessary—for analyzing coagulation in the vascular system. 
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CHAPTER II 
MECHANICAL MODEL BACKGROUND 
 
 Before evolution of a forming clot near an injury in vivo can be considered, the overall 
flow field must be determined. Though not implemented here (for reasons discussed in the 
following sections), a framework suitable for determination of the flow field—building on 
previous work by the authors which focused exclusively on the flow field—with suggested 
models and potential approximations are described below. 
Finite-volume discretization of the Reynolds transport equation (such as that employed 
by the commercial software Star-CCM+ [14]) allow for numerical solution of the flow fields. 
The most general expressions employed for continuity and momentum (referenced in the user 
guide) are given below as:  
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Where   is the density of the fluid,   is the velocity vector in a stationary reference 
frame,   is the area vector, p is the pressure, V is the volume,   is the identity matrix,   is the 
stress tensor, and    is the body force exerted over the volume considered in the simulation.  
The shear-thinning behavior of blood can be treated with the Carreau-Yasuda model (as 
in [3]) under which the viscosity varies as: 
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Where   is the dynamic viscosity, n is a power constant—roughly indicating the degree 
of shear-thinning behavior present—,  ̇ is the shear rate,    and    are the viscosities 
approached as shear rate approaches zero and increases without bound, respectively, and   and a 
are fit constants. (If    , the model reduces to the Carreau model.) 
The material data and boundary conditions used were from several different sources. The 
viscosity data was taken from Gijsen et al. 1998 [3], but the value for density was changed to be 
more consistent with that of whole blood (             instead of             ). The 
material parameters are as follows:      (  
  )    ,       (  
  )    ,        , 
       ,          .  
The boundary conditions (inlet speed and outlet pressure) used by the author of this study 
in previous work were based on a simplification of pulsatile waveforms (recorded for healthy 
adult patients) found in Zhao et al. 2002 [15]. Velocity was obtained in their study using Doppler 
anemometry near the carotid artery of a living subject (fully developed profiles at the inlet are 
assumed there and here); pressure was determined in a nearby region using an external pressure 
transducer.  
The following simplified equations were used: 
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Where  ̇ is the volumetric flow rate (mL/s),   is time, and R is the radius of the tube in 
millimeters.  
For Newtonian fluid flow through a pipe, the exact solution for fully developed flow 
shows that the velocity distribution is quadratic across the pipe cross-section. For non-Newtonian 
behavior, the resulting distribution will be flatter in the center (with higher velocity gradients at 
the wall) than in the Newtonian case, and so a fourth-order polynomial was used as a quick 
approximation: 
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Where        is the normalized radius. The pressure crest at the outlet tends to lag the 
velocity crest, so the pressure waveform was defined as: 
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Where     ( ) was chosen, as opposed to     ( ), to differentiate the width of the 
waveforms somewhat, qualitatively moving closer to the observed values shown graphically in 
Zhao et al. 2002 [15]. The heart rate used in this study was 60 BPM, which, conveniently, gives 
a complete pulse in 1 second. Pressure and volumetric flow rate are shown in Figure 1. 
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Figure 1. Volumetric flow rate specified at the inlet and backpressure specified at the outlet for a 
single heart beat in previous study 
 
 Due to the prolonged time scale at which clotting occurs ( 20 min or 1200 s), it is likely 
not important to use a pulsatile waveform for each second in a preliminary study. In this case, the 
stochastic transition model and reduced-order chemical ODEs are to be tested, but without 
advanced fluid-structure interaction and modeling of the high shear breakoff behavior of the 
platelet mass that forms, pulsatile flow behavior is not likely to dramatically influence the final 
outcome.  
 As such, root mean square values for the volumetric inlet flow rate and pressure outlet are 
used here: 
 ̇                    (8) 
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Where  ̇         is used with equations (5) and (6). 
In a previous research work by the author, three 2.5 mm radius, 75 mm length, 
axisymmetric representations of arteries (with varying degrees of stenosis—60, 75, and 80% by 
area) were used. In this work, a two-dimensional slice of these geometries—with no initial 
stenosis—is used. This keeps the resulting flow fields similar, but allows for observation of clot 
growth near an injury in the arterial wall. 
A rectilinear grid was used in the quiescent study, chosen to be appropriate for use with 
the flow study so direct comparison can be made. Finer mesh is present in the area near the 
―injured‖ section (in which the coagulation reaction is initiated in either case), as shown below 
(see Figure 2). 
 
 
 
 
Figure 2. (a) 2D mesh used over the computational domain; (b) Values for cell volume  
16 
CHAPTER III 
COAGULATION CHEMISTRY MODEL 
 
Background and Rationale 
The coagulation cascade involves a complex, highly regulated set of reactions intended to 
produce clots and maintain vascular integrity against injury (see Figure 3).  
Excellent models describing the kinetic behavior during reaction of the more than thirty 
species involved have been developed (see [9]). However, the time required to obtain a 
numerical solution at a single point renders computation over an entire spatial domain (in tandem 
with a flow simulation) intractable. 
 
 
Figure 3. The chemicals involved in the formation and regulation of Thrombin (IIa), the 
biochemical ultimately responsible for catalyzing the formation of Fibrin (Ia) and the 
construction of a clot (image source: [16]) 
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As seen in this figure, the aim of both extrinsic and intrinsic clotting pathways is the 
production of thrombin (factor IIa). Thrombin catalyzes soluble fibrinogen into insoluble fibrin, 
which, when acted upon by factor XIIIa, creates a cross-linked mesh, key to maintaining stability 
of the clot, though not sufficient (see Chapter IV) in itself to constitute a clot. 
A reduced order model proposed by one of the researchers in our lab ([17]) attempts to 
describe the most salient features of the coagulation cascade by focusing on the production of 
thrombin. With an appropriate fit, (in this case to the model used in Danforth et al. [9]) this 
reduction can be used to quickly replicate the concentrations predicted by a full model with only 
prothrombin (factor II), thrombin (IIa), antithrombin (AT), and IIa-ATIII.  
The four governing differential equations that constitute the reduction of the coagulation 
model are as follows: 
 
    
  
                  (11) 
     
  
                           (12) 
    
  
            (13) 
           
  
           (14) 
 
 Essentially, these equations determine thrombin concentration by considering its 
production from prothrombin and regulation by antithrombin (which produces the inactive 
reaction product IIa-ATIII). 
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Reduced-Order Model Assessment 
A programmatic method of fitting the coefficients in the reduced-order model was 
devised, and this was used to determine suitable values for the coefficients   ,   , and    that 
replicate performance by the full model. 
Results for a single run are shown below in Figure 4. 
 
  
Figure 4. (a) Full model of coagulation cascade results, (b) reduced model results with fit 
parameters 
 
 To assess the robustness of the model, the same process was employed for hundreds of 
test points, varying the initial concentrations of clotting factors over physiological ranges 
provided in Table 1.  
 Following a Latin Hypercube test design, values were chosen, constants   ,   , and    
were found, and normalized error (difference between full model and the approximate reduced-
order model species concentrations) was computed as: 
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Where   
    
 is the vector of concentrations for the ith reacting species predicted by the 
full model and   
        that predicted by the reduced-order fit, for the entire simulation time, 
  
 is the initial concentration of the ith reacting species, ‖ ‖  is the L2 norm, and the summation 
is carried out over the four species included in the reduced order model. 
 
Table 1. Initial concentration and average ranges of coagulation bio-chemicals for apparently 
healthy population (see [9]) 
 Initial Concentration (M) Normal Range (%) 
VII 1.00E-08 60 - 140 
VIIa 1.00E-10 60 - 140 
X 1.60E-07 60 - 140 
IX 9.00E-08 69 - 151 
II 1.40E-06 60 - 140 
VIII 7.00E-10 64 - 232 
V 2.00E-08 60 - 140 
TFPI 2.50E-09 46 - 171 
AT 3.40E-06 88 - 174 
 
 Configuring the optimization code to run in parallel, results were obtained in reasonable 
time using the supercomputer Ada. Some of these are shown in the figures below. 
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Figure 5. Normalized error over 30 points chosen using the Latin Hypercube experiment design 
 
 
Figure 6. Normalized error over 382 points chosen using the Latin Hypercube experiment design 
 
 The normed error was acceptably low (<9; for comparison, in Figure 4, the normed error 
is about 7) for all the data points; this indicates that the model is acceptably reliable for use in 
mechanical simulation. 
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Reduced-Order Model Fit 
 The values of   ,   , and    obtained above were determined for in each case for a single 
set of initial concentrations. However, in a mechanical flow simulation, chemical concentrations 
(and thus, the initial concentrations for the reactions carried out each time step) vary over the 
domain.  
To be useful for pairing with a mechanical simulation, the normalized error associated 
with the predicted concentrations cannot become too great for values encountered in the domain.  
Danforth et al. [9] indicates that the full model is initiated by introducing 5 pM 
concentration of TF to the system. In the reduced-order model, prothrombin behavior controls 
the production of thrombin.  
To determine suitable ranges for   ,   , and   , average physiological values were taken 
(Table 1) for the initial concentrations of species in the bloodstream before injury. TF was varied 
over the range (0, 5) pM, and the resulting values for  ,   , and    were observed (see Figure 7). 
 
 
Figure 7. Variation of reduced-order coefficients and normalized error with varying initial TF  
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Only    exhibits a distinct trend, with higher values for larger initial concentrations of TF 
and, notably, a value of zero for the steady-state case in which no TF is present and no reaction 
occurs.  
The other two coefficients erratic behavior is likely due to the imperfection of the 
optimization method used to minimize the error between the reduced and full models; it only 
uses a finite number of points on a finite interval of possibilities for the three coefficients, so 
some imprecision is to be expected. 
It makes sense that    exhibits TF-dependent behavior; it functions as a sort of ―gas 
pedal‖ for the key clotting reaction in which prothrombin is converted into thrombin. To avoid 
the additional computational burden of convecting and reacting the actual species that trigger the 
extrinsic pathway (TF with VII to VIIa, producing TF-VIIa or ―tenase‖; X to Xa acted on by 
tenase; and finally, the formation of Xa-Va, or ―prothrombinase‖, which will allow the 
production of thrombin (IIa) from prothrombin (II)), the value of the constants in a cell is used to 
determine whether species react. The reaction starts in injured cells that have constant values 
corresponding to a 0.5 pM TF trigger; as thrombin concentration becomes non-zero in the 
surrounding cells, their    values are flipped, and the reaction is allowed to spread. 
 
Table 2. Values of reduced-order model constants used in this study 
 Inactive Reacting 
      (  
  )    (    ) 
         (  
 )       (   ) 
           (  
 )  
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CHAPTER IV 
STOCHASTIC SPECIES TRANSPORT 
 
Theory and Rationale 
A typical finite volume implementation of the diffusion/advection equation to accomplish 
transport of species can tie up significant computational resources, especially as the number of 
species increases. Using a stochastic model could provide a reasonably accurate simplification. 
Given M cells, consider the probability  (     ) that some of the  (   ) particles in cell   
move to cell J at the end of time step   . If migration between each of the M cells is considered, 
it is evident that: 
 (      )  ∑ (     ) (   )
 
   
 (16) 
 
That is, the number of particles in cell J at time      is equal to the number of particles 
that enter J from all cells (including itself). We obtain a transition matrix when considering this 
process for all cells. 
An appropriate expression for the probability function P(     ) can be found by 
considering continuous solutions to the convection equation. 
 Spread of a chemical species throughout a medium is given by the differential equation: 
 
  
  
      ⃗ (17) 
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Where c is the concentration of the chemical, and  ⃗ is the flux. Under advection, the flux 
is given as: 
 ⃗    ⃗      (18) 
 
And 
  
  
   ⃗          (19) 
 
Where  ⃗ is the medium flow velocity and D is the diffusion constant. For a dirac delta type 
release in an infinite plane, with initially zero concentration, it can be shown that the solution to 
this equation is: 
 ( )  (
 
    
)
 
  
( ⃗  ⃗⃗ ) 
    (20) 
 
Where   is a radial coordinate, t is time, and n is an exponent that depends on the dimensionality.  
For zero velocity, concentration decays around a central peak as a bell curve; with the 
addition of advection (and non-zero velocity), the center and shape of the bell curve are skewed 
somewhat.  
Because equation (19) is linear, solutions due to multiple point releases over a domain 
can be combined as a linear combination. Discretizing equation (20) over a spatial domain with 
time steps   , the denominator normalizing factor for the continuous case can no longer be used; 
this gives pseudo-probabilities  ̅(     ) of a particle in cell I moving to cell J separated by   ⃗ as:  
 ̅(     )     ( 
(  ⃗    ⃗   )
 
    
) (21) 
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To generate probabilities P(     ), the pseudo-probabilities for all cells must be 
normalized so that the probabilities of movement for all particles from any cell I sums to unity at 
each time step and mass is conserved. That is, 
 (     )  
 ̅(     )
∑  ̅(     ) 
 (22) 
In words, the probability that a particle moves from cell I to J is equal to the pseudo-
probability a particle moves from cell I to J, divided by the sum of the pseudo-probabilities that 
that particle moves to any other cell J. 
The transition matrix that results can then be expressed as a sum of columns: 
 (      )  ∑(
 ̅(     )
∑  ̅(     ) 
) (   )
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] (24) 
Where M is the number of cells in the computational domain. This expression can be 
used to convect each species, even the chemical concentrations, due to the discrete nature of the 
numerical solution method. 
For a non-continuous set of particles, moved through discretized spatial cells in time 
steps   , this expression can be used to express the probability that some number of particles in 
one cell will move to any other, given the velocity field and initial distribution of particles. 
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It may appear prohibitive to compute this matrix given that likelihood of movement from 
one cell to another must be normalized by the likelihood of that movement occurring from the 
one cell to every other; in actuality, the probability of movement to the vast majority of cells will 
be (for all practical purposes) zero. We can posit a criterion for which probability is immediately 
set to zero: 
(  ⃗    ⃗   )
 
    
 
 
 
    ̅(     )       (     )    (25) 
 
That is, if the final position of a particle moving from cell I to cell J is three standard 
deviations (  ) or greater from the mean position anticipated, the corresponding pseudo-
probability is automatically set to zero. There is a less than 0.3% chance that the particle will end 
up in all cells that satisfy this criterion, and it is assumed that the probability is so low as to be 
effectively zero for computational convenience. 
 
Platelet and Chemical Species Implementation 
 The numerical values and simulation parameters selected to perform the computational 
analysis of this study will now be described here.  
For each of the convected species, the respective diffusion coefficient governs the extent 
of spread likely observed around the mean location the species tends towards when acted upon 
by the flowing velocity field of the surrounding blood.  
Values for the diffusion coefficients (estimated on the basis of molecular masses Mr) 
were taken from Panteleev et al. [18]; relevant data is shown in Table 3. Platelets were assumed 
not to diffuse in this study, because they are considerably more massive than all the other 
species. 
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Table 3. Diffusion coefficients for convected chemical species (modified from [18]; the 
diffusion coefficient for IIa-ATIII was added in this study); thrombomodulin (Tm) and its 
combination with thrombin (IIa-Tm) were not used in this study, but were used in the curve fit 
Model 
variable 
Mr 
Diffusion coefficient  
(mm
2
/min) (m
2
/s) 
II                  (     ) 
IIa                  (     ) 
AT-III                  (     ) 
IIa-ATIII                  (     ) 
Na (Platelets)             
IIa-Tm                   (     ) 
Tm                   (     ) 
 
A value for the diffusion coefficient of the aggregate IIa-ATIII was not provided, and 
was determined using a curve fit to the provided data (see Figure 8). 
 
Figure 8. Data and curve fit for molecular mass and its assumed relationship with the diffusion 
coefficient of relevant species 
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Spatial Discretization 
The combination of diffusion coefficient D, time step   , and average velocity  ̅ provide  
several important guidelines to be considered when selecting simulation parameters such as the 
spatial discretization for species convection     (which does not necessarily need to be the same 
as the spatial discretization for the macroscopic flow simulation, though in this study it is for 
simplicity).  
In particular,     must be small enough that convected species can actually escape a cell 
and move to another. The weaker condition requires that they move when acted upon by the 
velocity field: 
                      (
 
 
)  ̅   (26) 
 
The stronger condition requires that species be able to diffuse out of a cell into another. 
Considering the diffusion of the particles, if a three-cell spread is desired around the mean, then: 
 
            
√   
 
 (27) 
 
Where   is the smallest non-zero diffusion coefficient. Values obtained here (and 
guidelines in selecting the spatial discretization    ) are (assuming a time step          ): 
 
                  (28) 
 
            [         ](  
  )   (29) 
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It is evident that             and             present some conflicting restraints. If    is 
small, then             (required to observe any diffusion phenomena) will be prohibitively 
small. If, on the other hand,    is large, then             will be large and convected species will 
jump the entire length of the domain in a single time step.  
Time step           was selected as an attempt at compromise, and local refinement in 
the injured area was employed. This allows avoiding ultra-fine simulation everywhere on the one 
hand or full multi-scale on the other, but this precarious balancing act is clearly a weakness of 
the transport model that will need to be resolved for more robust implementation in the future.  
All cells within the             of the entry of the domain must be initialized each time 
step with starting concentrations (see Table 1) of all species, because the velocity field would 
cause entering species to jump over the region otherwise.  
Platelet initial concentration is determined assuming              or    (    )     , 
in which case                      (  
  )(  )   (In a 2D simulation, unit depth is assumed for 
volume calculations.) 
Diffusion Criteria 
 Diffusion and advection is allowed to occur freely throughout the computational domain, 
but as cell thrombin levels reach a threshold concentration, local platelets activate, and 
aggregates form, the flow behavior changes. 
 In particular, once a cell holds enough activated platelets to be considered a clot, cell 
viscosity is switched to a high value, slowing local velocity fields to near zero, and trapping 
platelets (which only move through advection in this model). Chemical species can still diffuse 
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out of the clotted area, which seems reasonable given the porous nature of the clot. The relevant 
threshold values are summarized in Table 4. 
Table 4. Threshold values used in simulation to determine cell flow and convection behavior. 
     is the concentration of thrombin in the cell,            is the number of platelets in the cell,   
is the dynamic viscosity 
 Criterion: 
Add cell to reaction zone         
Activate Cell         (  
  )   
Treat cell as clot            
    (  ) 
         
 
    (  ) 
 (     )
 
No more platelets allowed 
in cell 
           
    (  ) 
         
 
    (  ) 
 (     )
 
Clot cell viscosity         
Initialized length                   
 
The thrombin cell activation threshold is taken (arbitrarily) as    (    ) ; the number 
of platelets is taken as 40% of the maximum that could be packed into a unit cube with edge 
length    assuming deformation (74% is the ideal packing case for rigid spheres; platelets are 
deformable, but 74% is taken as the ultimate maximum, to account for porosity). 
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CHAPTER V 
RESULTS 
 
As discussed in the previous section, the time step required to simulate the combined 
stochastic convection/reduced-order chemical reaction model with a dynamically evolving flow 
field is small enough to require significant computational cost, simplifications notwithstanding.  
In this study, the processes of coagulation are simplified and resolved numerically for a 
quiescent (zero flow) case, to assess how well the reduced-order model handles the addition of 
diffusion and inform future work with the model.  
The two cases (quiescent and flowing) are contrasted with flow charts detailing the 
required operations (see Figure 9). 
 
    
Figure 9. Flow chart showing (a) suggested implementation of the flow model and (b) the actual 
implementation used for the quiescent model here 
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It is evident that the two do not differ much in implementation or in terms of the theory 
required for use; the most important difference is the required time step (and hence the number 
of evaluations of the transition matrix and reaction model ODEs). The simulation results for the 
quiescent case are presented below. 
Examination of Quiescent Clot Propagation 
 In the quiescent case, platelet action is neglected due to its (comparatively) small 
diffusion constant. Thus, cells are considered ―activated‖ (regions in which platelets activate and 
fibrin precipitates out of the blood) solely dependent on the thrombin concentration. 
 Reaction is started in a localized ―injured‖ area, and spreads out from there, first 
increasing and then reducing the concentration of thrombin, consistent with the behavior 
expected physiologically (Figure 10).  
 
 
Figure 10. Thrombin increase and diffusion from reaction zone (a) t = 1 s, (b) t = 11s, (c) t = 21s 
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For the first 530 seconds, thrombin concentration is still too low for anywhere in the 
region to be considered ―activated‖ (see Figure 4). Shortly after this point, however, thrombin 
exceeds the critical value and cells begin to be considered likely regions for clots to form, 
beginning in the injury region and following the diffusing and reacting thrombin outward.  
 
Figure 11. Cell activation at (a) t = 530 s, (b) t = 540 s, (c) t = 550 s 
 
 
Figure 12. Thrombin concentration at t = 530 s 
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 As the simulation approached 900 s (again, see Figure 4), thrombin, now diffused 
throughout the entire injury reaction region, begins to decrease in concentration as it is 
cannibalized by antithrombin (producing IIa-ATIII). 
 Initially, it was feared that the reduced-order model would diverge to unrealistic large 
concentration of thrombin with the ability to pull in almost limitless reactants from the 
surrounding space. In general, however, the reduced-order model exhibited behavior consistent 
with its 0-dimensional (in space) ordinary differential equation form and, more importantly, 
physiologically reasonable. 
 
Discussion of Numeric Behavior 
 As should be clear from the figures above, the reacting species were successfully bound 
within the ultra-fine reaction region, and did not diffuse through the rest of the domain. This is 
due to the lengths of the surrounding cells; in the time step provided, it is not probable for the 
concentrations to jump this discrete length. This limiting behavior can be used to reduce the 
computational load. 
 In regards to the computational load, it came disproportionately from use of the transition 
matrix. (In the domain used, it took ~ 10 times longer for an evaluation of the stochastic 
diffusion scheme than computation of the reacting species using Euler’s method.) 
 This is somewhat problematic. In a case involving advection, the time step must be made 
small to compensate for the transition matrix, and ensure physical displacements are made, thus 
this must be computed at each time step. The chemical reactions on the other hand could be 
computed only every couple of time steps (using a higher-order numerical solver, such as the 
RK-4 method), but it is unlikely that this would produce significant time savings. 
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CONCLUSION 
 
In this paper, a framework for less computationally expensive simulation of coagulation 
phenomena was assembled, and its use was demonstrated for a quiescent (no flow) case. It was 
shown that the reduced-order reaction model dealt with diffusion well, without catastrophic 
divergence of thrombin production, but instead with the controlled production and regulation 
demonstrated by the vascular system. 
Work here demonstrated weaknesses of the framework and key areas to focus on to better 
meet the goal of low computational cost, clinically feasible simulation. 
As discussed in previous sections, the spatial discretization required for observation of 
diffusion and controlled behavior of advection (            and            ) present some 
conflicting restraints. If    is small, then             will be prohibitively small. If, on the other 
hand,    is large, then             will be large and convected species will jump the entire length 
of the domain in a single time step.  
This means that selection of time step and spatial discretization require a precarious 
balancing act, a weakness of the stochastic transport model that will need to be resolved in 
future, more robust, implementations. Additionally, it was observed that the transition matrix 
was the most costly operation required, and future work should focus on fine-tuning its 
performance and evaluating only where necessary. 
The combined model has flexibility and reasonable simplification that make it attractive 
as a basis for patient-specific vascular modeling. 
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